Simplex Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Simplex Trading’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-75	Closed	-$136K	–	9494
2020 Q3	$136K	Buy	75 +73	+3,650%	+$1.04K	﹤0.01%	4571
2020 Q2	$2K	Sell	2 -2	-50%	-$31	﹤0.01%	7317
2020 Q1	$5K	Hold	4	–	–	﹤0.01%	6908
2019 Q4	$6K	Sell	4 -126	-97%	-$2.35K	﹤0.01%	6661
2019 Q3	$200K	Buy	130 +64	+97%	+$1.36K	﹤0.01%	3565
2019 Q2	$154K	Sell	66 -46	-41%	-$1.14K	﹤0.01%	3740
2019 Q1	$317K	Buy	112 +85	+315%	+$2.48K	﹤0.01%	3139
2018 Q4	$81K	Sell	27 -156	-85%	-$4.37K	﹤0.01%	4059
2018 Q3	$640K	Buy	+183	New	+$5.54K	﹤0.01%	2366

Simplex Trading's AKCA Position: Q4 2020 in Review

Simplex Trading sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 400 shares — an estimated $7K sold.

Simplex Trading first reported a position in AKCA in Q1 2019 and held it in 5 quarters. The position peaked at $37K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Simplex Trading reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Simplex Trading sold 400 Akcea Therapeutics Inc shares in Q4 2020, an estimated $7K.
Simplex Trading first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 5 quarters.
Simplex Trading's Akcea Therapeutics Inc position peaked at $37K in Q1 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.